Stay updated on Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.

Latest updates to the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to include new information about the clinical trial, specifically the addition of the study drug NT-001 and the involvement of collaborators Bristol-Myers Squibb. Additionally, the revision number has changed from v2.14.4 to v2.15.0.SummaryDifference44%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1.0%
Stay in the know with updates to Neo-PV-01 + Nivolumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-PV-01 + Nivolumab in Cancer Clinical Trial page.